News

The CDC recommends HCV testing for perinatally exposed infants and children to address the increasing incidence of hepatitis C among reproductive-age individuals, focusing on early detection and appropriate care.

At the Rockingham County Rehabilitation Center's Infection Control Fair, innovative and interactive approaches, including demonstrations, quizzes, and engaging activities, significantly promoted infection prevention education, making learning a fun and informative experience.

Recent CDC HICPAC revisions regarding SARS-CoV-2 control face criticism from the World Health Network and others due to alleged breaches in committee structure and erroneous infection control guidance, potentially impacting COVID-19 management and immunocompromised individuals in health care.

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending October 29, 2023.

A study led by Piyali Chatterjee, PhD, and the Central Texas Veterans Health Care System explores the potential of handheld filtered Far UV-C devices in reducing hospital-acquired infections. Freestyle Partners, LLC, supported this research.

A recent American Journal of Infection Control study, led by Katharine Hoffman, MPH, CIC, LSSGB, and Lisa Waldowski, DNP, RN, CIC, applies Lean Six Sigma to improve eye device reprocessing. The research highlights the challenges, emphasizes adherence to manufacturer instructions, and promotes best practices for patient safety.

Benjamin Chen, MD, MPH, speaks about how a journal watch in infection prevention keeps professionals updated on research, fosters evidence-based practices, and supports education and quality improvement efforts.

ICT speaks with Christopher Reid, PhD, a biological and biomedical Sciences professor, delving into his investigations on antibiotics and fungicides and how his team's investigations will "provide an extra tool in a clinician's" toolbox for treating bacterial fungal infections."

“Celebrate Clean Hospitals Day with us. We're an association that is trying to get out there and make people's lives a bit safer and better. Join us!” Alexandra Peters, PhD

The Executive Director of the Certification Board of Infection Control and Epidemiology (CBIC) addresses the eligibility guidelines for the Certification in Infection Prevention and Control (CIC) examination. While designed for success, these guidelines are not requirements, ensuring inclusivity for candidates from diverse infection prevention backgrounds. The CBIC emphasizes readiness and offers support to prospective CIC candidates.

Recent INFORM and EPOCH studies shed light on the significant risk and poor outcomes faced by immunocompromised individuals due to COVID-19, emphasizing the need for tailored prevention strategies.

Infection Control Today analyzes the surprising findings from its recent informal survey on the minimum educational requirement for infection preventionists.

In an interview with Amy Spallone, MD, from The University of Texas MD Anderson Cancer Center, the study investigates the effects of COVID-19 precautions on healthcare-associated infections, revealing surprising results in central line-associated bloodstream infections (CLABSIs), C difficile infections, and more.

International Infection Prevention and Control Week highlights the importance of preventing infections in health care and other settings. Share this poem to help educate others about IPC.

Building Information Modeling (BIM) plays a pivotal role in designing health care facilities that minimize infection risks, promoting efficient planning, and coordination while reducing construction challenges.

Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA, and SHEA Chair, highlights IDWeek 2023's hybrid format and discusses the critical topic of antimicrobial resistance, emphasizing the role of vaccines in reducing AMR.

At IDWeek 2023, a look into managing VAIs in children.

An immunocompromised keynote speaker, Kevin Kavanagh, MD, shares strategies for safe air travel during the COVID-19 pandemic, emphasizing mask usage, vaccinations, and air quality monitoring, with mixed observations throughout the journey.

A study of 28 nursing homes and nearly 29,000 residents reveals that universal decolonization significantly lowered infection-related hospitalizations, offering hope for improved healthcare outcomes.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending October 15, 2023.

A study in Maryland from June 2019 to December 2021 analyzed 140 Candida auris cases, revealing that patients often resided in disadvantaged neighborhoods with higher crowding, uninsured rates, and racial diversity. ICT speaks to the lead author.

A phase 3 trial presented at IDWeek 2023 shows that sulbactam-durlobactam (SUL-DUR) reduces mortality and improves outcomes in hospital-acquired Acinetobacter baumannii-calcoaceticus complex infections compared to colistin, offering a promising treatment option.

Meriwether County School District prioritizes student safety by implementing CASPR Technology, enhancing air and surface disinfection for a healthier learning environment.

Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.

Dr. Isaac Kohane explores AI's rapid medical evolution and the challenges of accuracy, updating, and education in infectious diseases at IDWeek 2023.

BiomX Develops BX004-A, a Phage Therapy, for Cystic Fibrosis Patients with Pseudomonas Infections. A phase 1b/2a study presents promising results at IDWeek 2023.

Wastewater-based surveillance can accurately monitor influenza A and B and RSV at the population level. This makes it an objective tool to inform public response to common seasonal illnesses.

This edition of Infection Intel from Infection Control Today covers infection control and prevention company news out of IDWeek, being held in Boston, Massachusetts, from October 11 to 15, 2023.

FDA approved emergency use of Novavax COVID-19 vaccine (NVX-CoV2601) for ages 12 years and older. It also protects against current variants.